Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nilay Sethi

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|June 14, 2005
Safety of serial monthly administration of triple-dose gadopentetate dimeglumine in multiple sclerosis patients: preliminary results of the BECOME trialLeo J Wolansky, Mohammad H Haghighi, Evangelia Sevdalis, et al.
JCI Insight|August 9, 2019
Mutant p53 induces a hypoxia transcriptional program in gastric and esophageal adenocarcinomaNilay Sethi, Osamu Kikuchi, James McFarland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2022
Development of Combination Strategies for Focal Adhesion Kinase Inhibition in Diffuse Gastric CancerKe Peng, Feifei Zhang, Yichen Wang, et al.
Cancers|December 23, 2022
Emerging Role of Targeted Therapy in Metastatic Pancreatic AdenocarcinomaBrandon M Huffman, Haley Ellis, Alexander C Jordan, et al.
Gut|April 15, 2024
Recurrent RhoGAP gene fusion CLDN18-ARHGAP26 promotes RHOA activation and focal adhesion kinase and YAP-TEAD signalling in diffuse gastric cancerFeifei Zhang, Varun Sahu, Ke Peng, et al.
Science Advances|April 29, 2022
A novel β-catenin/BCL9 complex inhibitor blocks oncogenic Wnt signaling and disrupts cholesterol homeostasis in colorectal cancerHelen Tanton, Tomasz Sewastianik, Hyuk-Soo Seo, et al.
Scientific Reports|November 23, 2023
Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinomaAurel Prosz, Haohui Duan, Viktoria Tisza, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinomaAurel Prosz, Haohui Duan, Viktoria Tisza, et al.
JCO Precision Oncology|January 12, 2023
Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal CancerRachel B Keller, Tali Mazor, Lynette Sholl, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|June 14, 2005
Safety of serial monthly administration of triple-dose gadopentetate dimeglumine in multiple sclerosis patients: preliminary results of the BECOME trialLeo J Wolansky, Mohammad H Haghighi, Evangelia Sevdalis, et al.
JCI Insight|August 9, 2019
Mutant p53 induces a hypoxia transcriptional program in gastric and esophageal adenocarcinomaNilay Sethi, Osamu Kikuchi, James McFarland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2022
Development of Combination Strategies for Focal Adhesion Kinase Inhibition in Diffuse Gastric CancerKe Peng, Feifei Zhang, Yichen Wang, et al.
Cancers|December 23, 2022
Emerging Role of Targeted Therapy in Metastatic Pancreatic AdenocarcinomaBrandon M Huffman, Haley Ellis, Alexander C Jordan, et al.
Gut|April 15, 2024
Recurrent RhoGAP gene fusion CLDN18-ARHGAP26 promotes RHOA activation and focal adhesion kinase and YAP-TEAD signalling in diffuse gastric cancerFeifei Zhang, Varun Sahu, Ke Peng, et al.
Science Advances|April 29, 2022
A novel β-catenin/BCL9 complex inhibitor blocks oncogenic Wnt signaling and disrupts cholesterol homeostasis in colorectal cancerHelen Tanton, Tomasz Sewastianik, Hyuk-Soo Seo, et al.
Scientific Reports|November 23, 2023
Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinomaAurel Prosz, Haohui Duan, Viktoria Tisza, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinomaAurel Prosz, Haohui Duan, Viktoria Tisza, et al.
JCO Precision Oncology|January 12, 2023
Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal CancerRachel B Keller, Tali Mazor, Lynette Sholl, et al.
Pageof 2